Byoung Joo Gwag
- Business
GNT Pharma’s GedaCure® Approved for the Treatment of Dogs With Cognitive Dysfunction Syndrome
Yongin, South Korea: GNT Pharma today announced the Korea Animal and Plant Quarantine Agency (APQA) has approved the New Drug…
Read More » - Health
GNT Pharma Announces Positive Top-Line Results in a Phase II Study of Nelonemdaz for Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy
Yongin, South Korea: Safety and Tolerability Established Good and Excellent Functional Outcome Increased GNT Pharma Inc. today reports positive top-line results…
Read More »